Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
Claudia Wahl(RWTH Aachen University), Roland M. Schmid(Tumkur University)
Cited by 737
Related Papers
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer
|New England Journal of Medicine|2012|184
Impaired Autophagy Induces Chronic Atrophic Pancreatitis in Mice via Sex- and Nutrition-Dependent Processes
|Gastroenterology|2014|180
Caveats of caveolin-1 in cancer progression
|Cancer Letters|2008|140
Bim and Noxa Are Candidates to Mediate the Deleterious Effect of the NF-κB Subunit RelA in Cerebral Ischemia
|Journal of Neuroscience|2006|135